Bio-Connect

METTL13 antibody

GTX120626
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetMETTL13
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    METTL13 antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:3000. IHC-P: 1:100-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID51603
  • Target name
    METTL13
  • Target description
    methyltransferase 13, eEF1A N-terminus and K55
  • Target synonyms
    5630401D24Rik, CGI-01, DFNB26, DFNB26M, DFNM1, EEF1AKNMT, KIAA0859, feat, eEF1A lysine and N-terminal methyltransferase, antiapoptotic protein FEAT, deafness (autosomal recessive, nonsyndromic) modifier 1, deafness (recessive, non-syndromic) modifier 1, deafness (recessive, nonsyndromic) modifier 1, eEF1A-KNMT, faint expression in normal tissues, aberrant overexpression in tumors, methyltransferase 13, eEF1A lysine and N-terminal methyltransferase, methyltransferase like 13, methyltransferase-like protein 13
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDQ8N6R0
  • Protein Name
    eEF1A lysine and N-terminal methyltransferase
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Wang X, Li K, Wan Y, et al. Methyltransferase like 13 mediates the translation of Snail in head and neck squamous cell carcinoma. Int J Oral Sci. 2021,13(1):26. doi: 10.1038/s41368-021-00130-8
    Read this paper
  • Liu Z, Sun T, Piao C, et al. METTL13 inhibits progression of clear cell renal cell carcinoma with repression on PI3K/AKT/mTOR/HIF-1α pathway and c-Myc expression. J Transl Med. 2021,19(1):209. doi: 10.1186/s12967-021-02879-2
    Read this paper